期刊文献+

烧伤病区铜绿假单胞菌对亚胺培南的耐药水平调查及药敏分析 被引量:2

Surveillance of resistant level of Pseudomonas aeruginosa to imipenem in burn wards and the analysis of their antimicrobial susceptibility
下载PDF
导出
摘要 目的 调查某烧伤中心住院患者烧伤创面分泌物、工作人员手、病区环境中分离的铜绿假单胞菌对亚胺培南的耐药水平 ,并比较亚胺培南敏感株和耐药株对常用抗菌药物的耐药性。方法 用E test试条法检测铜绿假单胞菌对亚胺培南的MIC值 ,用K B纸片法测定对其他 11种抗菌药物的敏感性。结果  132株铜绿假单胞菌对亚胺培南的MIC50 ,MIC90 ,MICgm(MIC几何均数 )分别为 1.5 ,32 ,1.94 μg/mL。对亚胺培南的耐药率为13.6 4 %。亚胺培南敏感组和耐药组比较 ,耐药株对 11种抗菌药物的耐药率普遍较敏感株高 ,一般相差 2倍以上。有 8株菌 (全部来源于严重烧伤患者 )对受试的 12种抗菌药物全部耐药。结论 临床细菌耐药性日益严重 ,应密切关注本地区甚至本病区细菌耐药性的变迁 ,适时调整治疗方案 ,合理应用抗菌药物。 Objective To survey the imipenem (IMP) resistance of Pseudomonas aeruginosa isolated from the in-patients, health care workers' hands and the environment of a burn center, and to compare the resistance of IMP susceptible isolates to commonly used antimicrobial agents with those of IMP resistant isolates. Methods The MIC values of Pseudomonas aeruginosa to IMP were determined by E-test strips and their susceptibility to other 11 antimicrobial agents were tested by the Kirby-Bauer method. Results The MIC 50 , MIC 90 and MIC gm of 132 isolates to IMP was 1.5 , 32 and 1.94 μg/mL , respectively. The total resistant rate to IMP was 13.64% . The resistant rates of IMP susceptible isolates to 11 antimicrobial agents were much higher than those of susceptible isolates. 8 strains isolated from serious burn patients were resistant to the total 12 antimicrobial agents. Conclusion The resistance of clinical bacteria was more serious than before. It is necessary to pay close attention to the bacteria resistant changes and to adjust the treatment plans at the right moment in order to use antimicrobial agents rationally.
出处 《中国感染控制杂志》 CAS 2004年第4期348-350,382,共4页 Chinese Journal of Infection Control
关键词 铜绿假单胞菌 亚胺培南 MIC 抗药性 微生物 微生物敏感性试验 Pseudomonas aeruginosa imipenem MIC drug resistance, microbial antimicrobial susceptibility test
  • 相关文献

参考文献12

  • 1[1]National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing;Twelfth Informational supplement, NCCLS documents M100-S12[S]. Pennsylvania: NCCLS, 2002. 1- 133.
  • 2许伟石.烧伤感染的经验性应用抗生素问题[J].中华烧伤杂志,2002,18(2):71-72. 被引量:43
  • 3[3]Kolar M, Latal T, Hajek V. Development of bacterial resistance to the third generation cephalosporins and their clinical use[J]. J Chenother, 1999, 11(4): 260-265.
  • 4蒋伟,常东,黄志红,张素霞.临床检出细菌的耐药现状分析[J].中华医院感染学杂志,2002,12(9):646-648. 被引量:75
  • 5徐盈斌,利天增,祁少海,沈锐,陈冬梅,贲晓松,邹艳红,邹永通.1993~1999年烧伤科细菌学调查及耐药性分析[J].中华烧伤杂志,2002,18(3):159-162. 被引量:29
  • 6许小敏,张民权,廖萍华,Xu Xiaomin,Zhang Minquan,LIAO Pinghua.烧伤病房细菌耐药性的分析[J].中华烧伤杂志,2001,17(2):19-23. 被引量:26
  • 7[7]Anwar H, Strap JL, Costerton JW. Establishment of aging biofilms: possible mechanism of bacterial resistance ro antimicrobial therapy[ J ]. Antimicrob Agents Chemother, 1992, 36 ( 7 ):1347 - 1351.
  • 8[8]Ichimiya T, Yamasaki T, Nasu M. In-vitro effects of entimicrobial agents on Pseudomonas aeruginosa biofilm formation[J].Antimicrob Chemother, 1994, 34(3): 331-341.
  • 9[9]Evans K, Poole K. The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa s growth-phase regulated [ J ].FEMS Microbiol Lett, 1999, 173(1): 35-39.
  • 10[10]Ochs M M, McCusker M P, Bains M, et al. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids[J]. Antimicrob A gents Chemother, 1999, 43(5): 1085- 1090.

二级参考文献35

  • 1王文奎,袁克俭,倪语星,孙珍,刘健,陈小琳.不同时期烧伤创面细菌生态学调查[J].中华烧伤杂志,2001,17(2):16-18. 被引量:33
  • 2金丽华,张民权.烧伤创面中多元耐药菌株的发生率[J].浙江医学,1995,17(5):315-316. 被引量:3
  • 3马纪平,苏建荣,靳景图.耐甲氧苯青霉素葡萄球菌[J].中华医学检验杂志,1996,19(3):186-188. 被引量:82
  • 4柴家科.烧伤感染的病原菌.见:盛志勇,郭振荣,主编.危重烧伤治疗与康复学,2000.127-130.
  • 5Cook N. Methicillin resistant Staphylococcus aureus versus the burn patient. Burns.1998,24:91-98.
  • 6R. Kumar Gang,Rameshwar L.Bang,Suhas C.Sanyal,et al.Pseudomanas aeruginosa septicaemia in burns.Burns,1999,25:611-616.
  • 7Gin AS,Zhanel GG.Vancomycin resistance Enterococci.Ann Pharmacother,1996,30:615-624.
  • 8Pruitt BA,Jr. McManus AT,Kim SH,et al.Burn Wound Infection: Current status.Would J.Surg,1998,22:135-145.
  • 9Murthy SK, Balch AL, Smith RP, etal. Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients[J]. JClin Microbiol, 1989, 27(1):35-40
  • 10National Committee for Clinical Laboratory Standard. Approved standardM7-A4.Methods for dilution antimicrobiol susceptibility tests for bacteria that growaerobically[S]. 4*!th ed, NCCLS, Villanova, Pa. 1997

共引文献214

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部